News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Brandon Sheffield: Canadian Expert Consensus on Predictive Biomarker Testing in Gastric and GEJ Adenocarcinoma
cancerhealth.com
Dec 13, 2024, 16:02

Brandon Sheffield: Canadian Expert Consensus on Predictive Biomarker Testing in Gastric and GEJ Adenocarcinoma

Brandon Sheffield, Diagnostic and Molecular Pathologist at William Osler Health System, shared on LinkedIn:

“Great new resource for pathologists and oncologists!

A lot has changed in gastric cancer, we have a lot of new therapies to offer. Pathologists are playing a big part here with Claudin18 becoming the latest IHC biomarker coming into play for precision medicine in gastric cancer patients.

Read on to see some helpful recommendations from Canadian pathologists and oncologists.”

Canadian Consensus Recommendations for Predictive Biomarker Testing in Gastric and Gastroesophageal Junction Adenocarcinoma

Authors: Christine Brezden-Masley, Pierre O. Fiset, Carol C. CheungThomas Arnason, Justin Bateman, Martin Borduas, Gertruda Evaristo, Diana N. Ionescu, Howard J. Lim, Brandon S. Sheffield, Sara V. Soldera, Catherine J. Streutker

Brandon Sheffield: Canadian Expert Consensus on Predictive Biomarker Testing in Gastric and GEJ Adenocarcinoma

Brandon S. Sheffield Brandon Sheffield cancer Carol C. CheungThomas Arnason Catherine J. Streutker Christine Brezden-Masley Diana N. Ionescu Gertruda Evaristo Howard J. Lim Justin Bateman Martin Borduas OncoDaily Oncology Pierre O. Fiset Sara V. Soldera
Special Coverage
Blog
Dec 13, 2024, 17:37
Moffitt Cancer Center - Potential avenues for toxicity prevention and therapeutic optimization in high-risk patients
Blog
Dec 13, 2024, 17:33
Elizabeth F. Franklin: Learning about the newest science in blood cancers and disorders
Blog
Dec 13, 2024, 17:07
Supriya Peshin: Exceptional opportunity to present my posters at the prestigious ASH24
Insight
Dec 13, 2024, 17:04
Sana Sukhun: SHR-A1811 demonstrating non-inferiority to the standard quadruple therapy in early Breast Cancer
Insight
Dec 13, 2024, 17:01
Arya Roy: Important study from Matteo Lambertini and colleagues at SABCS2024
Insight
Dec 13, 2024, 16:57
Akhil Santhosh: IO added to CTRT doesn't work in stage 3 NSCLC
Insight
Dec 13, 2024, 16:55
Arya Roy: Exciting results from EMBER-3 study
Insight
Dec 13, 2024, 16:50
Francisco J. Esteva: The clinical validation results of Ataraxis Breast at SABCS24
Insight
Dec 13, 2024, 16:47
Erika Hamilton presented results from a post-hoc exploratory analysis of the NATALEE trial at SABCS24
Insight
Dec 13, 2024, 16:45
Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL
Insight
Dec 13, 2024, 16:40
Monica Bertagnolli: AI System Has Potential to Differentiate Brain Cancer from Healthy Tissue During Surgery
Blog
Dec 13, 2024, 16:21
Francisco J. Esteva: Kicking off SABCS24 with the amazing breast cancer team from Northwell Cancer Institute